Go Pro
→ Central banks bought 710 tonnes - this fund pays monthly (From Investors Alley) (Ad)tc pixel Free DSGN Stock Alerts

Design Therapeutics (DSGN) Short Interest Ratio & Short Volume

Design Therapeutics logo
$14.83 +0.44 (+3.06%)
Closing price 04:00 PM Eastern
Extended Trading
$14.81 -0.02 (-0.13%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Design Therapeutics Short Interest Overview

As of July 31, 2026, Design Therapeutics (DSGN) had a short interest of 5.95 million shares sold short, representing 11.47% of the public float. This marks a 4.99% increase in short interest since the prior report. The short interest ratio (days to cover) is 12.0, meaning it would take 12.0 days of the average trading volume of 440,906 shares to cover all short positions.

Current Short Interest
5,952,223 shares
Previous Short Interest
5,669,571 shares
Change Vs. Previous Month
4.99%
Dollar Volume Sold Short
$72.50 million
Short Interest Ratio
12.0 Days to Cover
Last Record Date
July 31, 2026
Outstanding Shares
62,580,000 shares
Short Percent of Float
11.47%
Today's Trading Volume
259,839 shares
Average Trading Volume
440,906 shares
Today's Volume Vs. Average
59%
Short Selling Design Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Design Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

DSGN Short Interest Over Time

DSGN Days to Cover Over Time

DSGN Percentage of Float Shorted Over Time

Design Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/20265,952,223 shares $72.50 million +5.0%11.5%11.96 $12.18
7/15/20265,669,571 shares $76.65 million -0.8%10.9%6.36 $13.52
6/30/20265,715,760 shares $82.71 million +23.4%11.0%5.16 $14.47
6/15/20264,631,963 shares $51.60 million +19.5%8.9%6.25 $11.14
5/29/20263,876,597 shares $40.63 million +33.5%7.5%1.91 $10.48
5/15/20262,903,656 shares $41.73 million +25.1%6.1%5.34 $14.37
4/30/20262,321,731 shares $31.58 million +3.7%4.9%3.57 $13.60
4/15/20262,238,096 shares $28.54 million +7.6%4.3%6.81 $12.75
3/31/20262,079,920 shares $22.13 million +6.1%4.0%6.22 $10.64
3/13/20261,961,343 shares $19.85 million +12.8%4.2%9.2 $10.12
2/27/20261,738,497 shares $18.15 million -3.6%3.4%9.37 $10.44
2/13/20261,803,282 shares $18.16 million -9.5%3.5%9.42 $10.07
1/30/20261,993,557 shares $20.35 million -14.0%4.6%5.63 $10.21
1/15/20262,317,010 shares $21.69 million +3.8%5.3%8.87 $9.36
12/31/20252,232,251 shares $20.94 million +5.3%5.1%3.18 $9.38
12/15/20252,119,760 shares $19.33 million +0.7%4.9%7.27 $9.12
11/28/20252,105,995 shares $20.22 million +5.1%4.8%6.79 $9.60
11/14/20252,004,465 shares $14.77 million +8.4%4.6%3.21 $7.37
10/31/20251,849,031 shares $12.39 million -3.1%4.2%15.02 $6.70
10/15/20251,910,000 shares $12.82 million -46.2%6.1%10.8 $6.71
9/30/20253,550,000 shares $26.73 million -3.5%11.4%23.9 $7.53
9/15/20253,680,000 shares $21.56 million +4.6%11.8%25.5 $5.86
8/31/20253,520,000 shares $19.47 million +0.3%11.3%29 $5.53
8/15/20253,510,000 shares $18.71 million +0.6%11.3%31.8 $5.33
7/31/20253,490,000 shares $13.51 million -1.1%11.3%36.9 $3.87
7/15/20253,530,000 shares $13.84 million -2.5%11.4%35.1 $3.92
6/30/20253,620,000 shares $12.20 million -0.8%11.7%30.4 $3.37
6/15/20253,650,000 shares $14.02 million -0.3%11.8%32.3 $3.84
5/31/20253,660,000 shares $13.65 million -0.8%11.9%30.8 $3.73
5/15/20253,690,000 shares $12.40 million +4.2%12.0%26.1 $3.36
4/30/20253,540,000 shares $17.20 million +2.0%11.5%23.4 $4.86
4/15/20253,470,000 shares $11.52 million +4.5%11.2%23.9 $3.32
3/31/20253,320,000 shares $12.82 million +1.5%10.8%20.4 $3.86
3/15/20253,270,000 shares $15.37 million +1.6%10.6%18.9 $4.70
2/28/20253,220,000 shares $15.65 million +2.6%10.5%16.8 $4.86
2/15/20253,140,000 shares $12.81 million -0.6%10.2%18.2 $4.08
1/31/20253,160,000 shares $15.33 million +1.9%10.1%17.5 $4.85
1/15/20253,100,000 shares $13.52 million +6.2%9.9%17.8 $4.36
12/31/20242,920,000 shares $18.02 million +8.2%9.3%17.2 $6.17
12/15/20242,700,000 shares $15.12 million -0.4%8.6%15.7 $5.60
After KDA, PRE, and OCEAN—this is the one (Ad)

17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of. But the world's largest bank is already building on it. It has a deflationary burn mechanism tied directly to institutional usage.tc pixel

Click to see my #1 pick.
11/30/20242,710,000 shares $16.26 million +0.7%8.6%11.2 $6.00
11/15/20242,690,000 shares $15.60 million +3.9%8.6%11.4 $5.80
10/31/20242,590,000 shares $13.57 million -1.2%8.1%10.9 $5.24
10/15/20242,620,000 shares $14.12 million +1.6%8.2%9.7 $5.39
9/30/20242,580,000 shares $13.88 million -0.4%8.0%9.7 $5.38
9/15/20242,590,000 shares $14.35 million +18.3%8.1%9.7 $5.54
8/31/20242,190,000 shares $10.40 million -25.5%6.8%8.7 $4.75
8/15/20242,940,000 shares $12.61 million -17.4%9.2%15.7 $4.29
7/31/20243,560,000 shares $18.16 million +16.7%10.7%17.3 $5.10
7/15/20243,050,000 shares $13.66 million +3.4%9.2%14.5 $4.48
6/30/20242,950,000 shares $9.88 million +2.8%8.9%12.4 $3.35
6/15/20242,870,000 shares $10.65 million +2.5%8.7%10.8 $3.71
5/31/20242,800,000 shares $11.34 million -1.8%8.4%9.6 $4.05
5/15/20242,850,000 shares $12.85 million -4.7%8.6%9.6 $4.51
4/30/20242,990,000 shares $10.52 million +25.1%9.1%9.8 $3.52
4/15/20242,390,000 shares $9.06 million +7.2%7.2%9.3 $3.79
3/31/20242,230,000 shares $8.99 million +4.2%6.8%9 $4.03
3/15/20242,140,000 shares $5.52 million -24.9%6.5%8.2 $2.58
2/29/20242,850,000 shares $7.92 million +1.1%8.8%11.3 $2.78
2/15/20242,820,000 shares $7.16 million +16.1%8.7%9 $2.54
1/31/20242,430,000 shares $5.76 million -3.2%7.5%6.2 $2.37
1/15/20242,510,000 shares $6.12 million -11.0%7.7%5.8 $2.44
12/31/20232,820,000 shares $7.47 million +9.7%8.7%6.6 $2.65
12/15/20232,570,000 shares $6.58 million -19.2%7.9%6.1 $2.56
11/30/20233,180,000 shares $7.63 million +1.6%9.8%7.4 $2.40
11/15/20233,130,000 shares $7.26 million +0.3%9.6%5.2 $2.32
10/31/20233,120,000 shares $6.36 million +6.1%9.6%3.3 $2.04
10/15/20232,940,000 shares $6.29 million +0.7%9.0%3.2 $2.14
9/30/20232,920,000 shares $6.89 million +2.1%9.0%3.2 $2.36
9/15/20232,860,000 shares $7.35 million +24.4%8.8%3.2 $2.57
8/31/20232,300,000 shares $5.70 million -42.2%7.1%2.6 $2.48
8/15/20233,980,000 shares $8.62 million -41.0%12.2%6.2 $2.17
7/31/20236,750,000 shares $54.95 million -2.3%20.8%30.3 $8.14
7/15/20236,910,000 shares $47.96 million -0.4%21.3%26.7 $6.94
6/30/20236,940,000 shares $43.72 million -7.2%21.3%26.4 $6.30
6/15/20237,480,000 shares $40.99 million +5.2%23.0%27.1 $5.48
5/31/20237,110,000 shares $40.03 million -5.0%21.9%19.9 $5.63
5/15/20237,480,000 shares $50.94 million +35.5%23.0%19.1 $6.81
4/30/20235,520,000 shares $35.60 million +2.6%17.0%13.1 $6.45
4/15/20235,380,000 shares $27.92 million -3.2%16.5%12 $5.19
3/31/20235,560,000 shares $32.08 million -23.9%17.1%12.4 $5.77
3/15/20237,310,000 shares $51.24 million -3.1%22.5%15.4 $7.01
2/28/20237,540,000 shares $53.31 million +5.2%23.2%13.1 $7.07
2/15/20237,170,000 shares $49.26 million -1.2%22.1%12.7 $6.87
1/31/20237,260,000 shares $56.99 million +8.2%25.1%13.2 $7.85
1/15/20236,710,000 shares $60.39 million +3.1%20.7%12.6 $9.00
12/30/20226,510,000 shares $66.79 million +28.9%21.2%12.9 $10.26
12/15/20225,050,000 shares $40.96 million +11.5%20.2%9.8 $8.11
11/30/20224,530,000 shares $63.42 million -10.7%14.3%11.2 $14.00
11/15/20225,070,000 shares $72.30 million -1.7%16.0%14.5 $14.26
Central banks bought 710 tonnes - this fund pays monthly (Ad)

Gold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan is now targeting $4,900. One $15 fund is converting gold's momentum into up to $1,152 per month in payouts. No miners, no active trading - just monthly income.tc pixel

See how to collect your first payout before the next surge
10/31/20225,160,000 shares $80.60 million +7.3%16.6%15.6 $15.62
10/15/20224,810,000 shares $75.90 million -11.4%15.5%16.1 $15.78
9/30/20225,430,000 shares $90.79 million +23.7%17.5%19.6 $16.72
9/15/20224,390,000 shares $99.78 million +10.6%14.1%16.6 $22.73
8/31/20223,970,000 shares $80.43 million -14.4%12.8%19.8 $20.26
8/15/20224,640,000 shares $118.64 million +14.6%14.9%24.6 $25.57
7/31/20224,050,000 shares $79.46 million -4.0%13.0%22.4 $19.62
7/15/20224,220,000 shares $77.82 million -1.4%13.6%20.7 $18.44
6/30/20224,280,000 shares $59.92 million +2.9%13.8%21.3 $14.00
6/15/20224,160,000 shares $56.95 million -7.6%13.4%21.5 $13.69
5/31/20224,500,000 shares $56.16 million +10.0%14.5%27.8 $12.48
5/15/20224,090,000 shares $44.70 million +0.7%13.2%25.5 $10.93
4/30/20224,060,000 shares $48.48 million +37.2%13.1%26.2 $11.94
4/15/20222,960,000 shares $45.11 million +2.4%9.6%18.6 $15.24
3/31/20222,890,000 shares $46.67 million -3.0%9.4%19 $16.15
3/15/20222,980,000 shares $51.91 million +20.7%10.5%19.2 $17.42
2/28/20222,470,000 shares $33.52 million +14.4%8.7%12.4 $13.57
2/15/20222,160,000 shares $31.92 million -4.9%9.5%11 $14.78
1/31/20222,270,000 shares $28.69 million +4.1%8.0%11.5 $12.64
1/15/20222,180,000 shares $34.55 million No ChangeN/A0 $15.85
12/31/20212,180,000 shares $46.67 million -19.3%7.7%12.4 $21.41
12/15/20212,700,000 shares $54.97 million +11.6%9.6%15.4 $20.36
11/30/20212,420,000 shares $40.51 million +25.4%8.6%21.2 $16.74
11/15/20211,930,000 shares $38.41 million +38.9%6.8%18.8 $19.90
10/29/20211,390,000 shares $21.80 million +0.7%4.9%15.7 $15.68
10/15/20211,380,000 shares $19.67 million -14.3%4.9%16.4 $14.25
9/30/20211,610,000 shares $23.65 million -3.6%5.7%20.3 $14.69
9/15/20211,670,000 shares $26.12 million +9.9%5.9%15.3 $15.64
8/31/20211,520,000 shares $23.89 million -26.6%5.4%11 $15.72

DSGN Short Interest - Frequently Asked Questions

Short interest is the volume of Design Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 5,952,223 shares of DSGN short. 11.47% of Design Therapeutics' shares are currently sold short. Learn More on Design Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DSGN shares currently have a short interest ratio of 12.0. Learn More on Design Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.47% of Design Therapeutics' floating shares are currently sold short.

Design Therapeutics saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 5,952,223 shares, an increase of 5.0% from the previous total of 5,669,571 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

11.47% of Design Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Design Therapeutics: IDEAYA Biosciences, Inc. (12.08%), MBX Biosciences, Inc. (15.63%), uniQure N.V. (16.15%), GRAIL, Inc. (17.09%), Celldex Therapeutics, Inc. (10.25%), Disc Medicine, Inc. (20.01%), Beam Therapeutics Inc. (23.65%), Immunome, Inc. (17.11%), Kodiak Sciences Inc. (29.40%), CareDx, Inc. (12.15%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.50 billion), Invesco QQQ ($50.36 billion), iShares Russell 2000 ETF ($21.20 billion), Western Digital Corporation ($13.40 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($11.46 billion), iShares 20+ Year Treasury Bond ETF ($7.84 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.51 billion), iShares Semiconductor ETF ($6.37 billion), and Financial Select Sector SPDR Fund ($6.34 billion). View all of the most shorted stocks.

Short selling DSGN is an investing strategy that aims to generate trading profit from Design Therapeutics as its price is falling. DSGN shares are trading up $0.44 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Design Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DSGN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DSGN, twice per month. The most recent reporting period available is July, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like DSGN:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:DSGN is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/11/2026. FINRA publishes updated short interest twice a month.
From Our Partners
AI insiders stockpile guns, gold & gas masks
Keith Kaplan, CEO of TradeSmith, has spent more than $17 million studying AI since 2022. He says a major shift...
TradeSmith | Sponsoredtc pixel
Wall Street is staring at the wrong AI trade
Anthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
After KDA, PRE, and OCEAN—this is the one
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...
Crypto 101 Media | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel